CardiaCare Archives - Medical Design Sourcing

CardiaCare names Ken Nelson as chair of its board

CardiaCare announced that it appointed digital health, medical device and remote patient monitoring veteran Ken Nelson as its board chair.

Nelson brings 20 years of medtech experience, including a track record of building successful sales, marketing and commercialization teams.

“Ken brings a wealth of market development, commercialization and sales experience in the cardiac monitoring and cardiac rhythm management space,” said Ofer Halbreich, CEO of CardiaCare.

Halbreigh added that Nelson joins as CardiaCare ramps up multiple clinical trials for its wearable device for AFib treatment.

The clinical-stage digital therapeutic company develops a closed-loop wearable device. It offers a noninvasive treatment for cardiac and other central nervous system-related clinical symptoms. The nerve stimulation system has continuous monitoring and AI-based alert capabilities. It enables complete remote patient management and personalized treatment. Read more

CardiaCare to partner with Dr. Reddy’s Laboratories in India

CardiaCare recently announced it signed a strategic licensing agreement with Dr. Reddy’s Laboratories to further develop CardiaCare’s wearable atrial fibrillation treatment device.

Through the agreement, Dr. Reddy’s Laboratories will lead necessary clinical studies for CardiaCare to receive regulatory clearance in India.

CardiaCare is developing a non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment. It will receive undisclosed upfront and royalty payments, while Dr. Reddy’s will manage commercialization and distribution in India.

The agreement will make India the first market to offer a home-care digital therapeutic for AFib patients, according to the news release posted Dec. 15. Headquartered in Hyderabad, Dr. Reddy’s had $2.8 billion in revenue in its most recent fiscal year. It’s one of a number of major pharmaceutical companies based out of India.

CardiaCare to partner with Dr. Reddy’s Laboratories in India

CardiaCare recently announced it signed a strategic licensing agreement with Dr. Reddy’s Laboratories to further develop CardiaCare’s wearable atrial fibrillation treatment device.

Through the agreement, Dr. Reddy’s Laboratories will lead necessary clinical studies for CardiaCare to receive regulatory clearance in India.

CardiaCare is developing a non-invasive, personalized neuromodulation wearable for atrial fibrillation treatment. It will receive undisclosed upfront and royalty payments, while Dr. Reddy’s will manage commercialization and distribution in India.

The agreement will make India the first market to offer a home-care digital therapeutic for AFib patients, according to the news release posted Dec. 15. Headquartered in Hyderabad, Dr. Reddy’s had $2.8 billion in revenue in its most recent fiscal year. It’s one of a number of major pharmaceutical companies based out of India.

“We look forward to w…